MedPath

Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease

Not Applicable
Completed
Conditions
Alzheimer's Disease
Registration Number
NCT02708485
Lead Sponsor
Université de Sherbrooke
Brief Summary

The aim of this study is to evaluate the effect of a 3-month walking program on brain energy metabolism in patient with mild Alzheimer's disease (AD). Two groups of sedentary patients with mild AD are followed and compared over a 3-month period of time: Control (non-active) and walking (from 15 to 45 minutes of exercise on a treadmill, 3 times a week for 12 weeks) groups. All the participants are evaluated on their cognition, brain volumes (MRI) and brain fuel consumption (PET scan with 18-FDG and 11C-AcAc) at the beginning and at the end of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Diagnosis of mild Alzheimer's disease (NINCDS-ADRDA criteria)
  • Taking cholinesterase inhibitors
  • Sedentary
  • Ability to do physical exercise
Exclusion Criteria
  • Parkinson disease
  • Down syndrome
  • Epilepsy or concussion
  • Drug or alcohol abuse
  • Past psychiatric history
  • Vitamin B12 Deficiency
  • Uncontrolled diabetes or thyroid function

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Brain Glucose Consumption3 months

Brain glucose uptake (umol/100g/min) using 18F-FDG PET imaging

Brain Acetoacetate Consumption3 months

Brain acetoacetate uptake (umol/100g/min) using 11C-AcAc PET imaging

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)

🇨🇦

Sherbrooke, Quebec, Canada

Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)
🇨🇦Sherbrooke, Quebec, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.